DANBURY, Conn., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) announced today that management will be presenting an overview of the company's technologies, development programs, and outlook at the 2013 BIO CEO and Investor Conference on Monday, February 11, 2013 at 3:00 p.m. ET during the conference to be held February 11-12, 2013, at the Waldorf Astoria Hotel in New York City.
A live and archived webcast of the presentation will be accessible by visiting the Biodel website at www.biodel.com under "Webcasts" in the "News & Events" section.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles.
Seth D. Lewis, +1-646-378-2952